ARCHIVES

Modality Combo Decreases Prostate Cancer Recurrence

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

Blincyto Demonstrates Response In Minimal Residual Disease ALL

December 26, 2014

Gene Therapy Experiments Get RDAC Okay

August 10, 1990

Clinical Trials Renew By NCI Gets Under Way

May 3, 1985

NCI Not Following Congress Mandate, Zubrod Contends

April 28, 1978

Haller Named Editor-In-Chief Of JCO; White House Appoints Duffy To NCAB.

March 17, 2000

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997